News and Events
 | Largest study of ‘baby brain’ reveals that new parents are as astute as non-parents 29 May 2026 The largest and most comprehensive study of memory and cognition in new parents has found no evidence for 'baby brain' in mums and dads. In a study published in the journal Cortex, and led by PhD candidate Navyann Siddiqui and Dr Kelsey Perrykkad from the Cognitive Neuroimaging Lab at the Turner Institute for Brain and Mental Health, researchers examined cognitive differences in 150 birth-giving mothers and 150 non-birth-giving fathers up to two years after their baby's birth. |
 | Monash advancing medical breakthroughs with Victorias most advanced MRI Scanner 4 December 2025 Monash Biomedical Imaging will today launch Victoria’s most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate breakthroughs in critical health challenges like dementia, schizophrenia, addiction, epilepsy and cancer. |
 | Alex Fornito awarded ARC Laureate Fellowship 30 August 2022 We are thrilled to announce that Professor Alex Fornito has been awarded a prestigious ARC Laureate Fellowship for 5 years titled "Next-generation maps and models of the human brain". The scheme supports exceptional, world-class researchers to undertake groundbreaking and transformational research and to foster an excellent research training environment and exemplary mentorship to nurture early-career researchers. This year, in total 16 fellowships were awarded across the country, making them extremely competitive |
 | Focused ultrasound for treating brain tumours 13 April 2022 Finding an effective treatment for brain tumours has challenged researchers for decades, partly due to the impenetrability of the Blood Brain Barrier (BBB). Focused Ultrasound (FUS) enhances drug delivery and accumulation to infiltrating tumour regions by inducing targeted, temporary disruption of the BBB. Monash Biomedical Imaging's Dr Ekatarina Salimova is using this innovative technique to find new treatment targets in preclinical models of glioblastoma. Dr Salimova and colleagues have recently published a comprehensive review paper on the current translational status of the preclinical FUS research in the Journal of Controlled Release. |
 | $71M Australian Precision Medicine Enterprise project 4 April 2022 Monash Biomedical Imaging is part of the new $71.2 million Australian Precision Medicine Enterprise (APME) facility, which brings together industry partners Global Medical Solutions Australia (GMSA) and Telix Pharmaceuticals with Monash University. The APME will deliver large-scale development and manufacturing of precision medicines and theranostic radiopharmaceuticals for industry and research. The project has received $23 million from the Australian Federal Government. A key feature of the APME project is a high-energy cyclotron with multiple production clean rooms, which will be located on the Monash Biomedical Imaging site in Clayton. This strategic co-location will facilitate radiochemistry, PET and SPECT research and clinical use of theranostic (therapeutic and diagnostic) radioisotopes produced on-site. Read the Monash University announcement. Visit the APME Website and LinkedIn. |
 | Triceratops comes to life with CT imaging 16 March 2022 Computer Tomography (CT) scans of a 67-million-year-old Triceratops acquired at Monash Biomedical Imaging have been used to create an immersive digital experience as part of the dinosaur’s exhibition at the Melbourne Museum. Data from the scans produced by MBI’s large bore Siemens CT scanner will also be digitally archived and maintained by the Museum. |